Cell type-specific effects of Rb deletion in the murine retina

  1. David MacPherson1,2,
  2. Julien Sage1,2,4,
  3. Teresa Kim1,2,
  4. Dennis Ho1,2,
  5. Margaret E. McLaughlin1,2, and
  6. Tyler Jacks1,3,5
  1. 1Department of Biology and 2Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA; 3Howard Hughes Medical Institute, Chevy Chase, Maryland 20185, USA

Abstract

Certain cells of the human retina are extremely sensitive to loss of function of the retinoblastoma tumor suppressor gene RB. Retinoblastomas develop early in life and at high frequency in individuals heterozygous for a germ-line RB mutation, and sporadic retinoblastomas invariably have somatic mutation in the RB gene. In contrast, retinoblastomas do not develop in Rb+/- mice. Although retinoblastoma is thought to have developmental origins, the function of Rb in retinal development has not been fully characterized. Here we studied the role of Rb in normal retinal development and in retinoblastoma using conditional Rb mutations in the mouse. In late embryogenesis, Rb-deficient retinas exhibited ectopic S-phase and high levels of p53-independent apoptosis, particularly in the differentiating retinal ganglion cell layer. During postnatal retinal development, loss of Rb led to more widespread retinal apoptosis, and adults showed loss of photoreceptors and bipolar cells. Conditional Rb mutation in the retina did not result in retinoblastoma formation even in a p53-mutant background. However, on a p107- or p130-deficient background, Rb mutation in the retina caused retinal dysplasia or retinoblastoma.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article published online ahead of print. Article and publication date are at http://www.genesdev.org/cgi/doi/10.1101/gad.1203304.

  • 4 Present address: Department of Pediatrics and Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.

  • 5 Corresponding author. E-MAIL tjacks{at}mit.edu; FAX (617) 253-9863.

    • Accepted May 18, 2004.
    • Received March 16, 2004.
| Table of Contents

Life Science Alliance